Golden Helix Newsletter

CIO Review
20 Most Promising Biotech Technology Solution Providers
by Cheryl Rogers,
Director of Marketing

This month, CIO Review released a Biotech Technology Special in which Golden Helix was named among the 20 most promising biotech technology solution providers for 2016.

Our customers are monumental in this honor and we appreciate their continued support, praise and referrals as we strive to provide the best analytics software available for both researchers and clinicians.
Read the full interview here »

Education eBook

New Teaching Bioinformatics Concepts & Practical Skills eBook!
by Andreas Scherer,
CEO & President

New breakthroughs are being made every day in genomics. It's a dynamic and fascinating industry, and with exceptional growth forecasted in the DNA sequencing market, a new generation of people are entering the field: future researchers, clinicians, counselors and doctors. This new generation will need to learn not only the science, but also understand how to process the massive amounts of data generated with DNA sequencing (and genomics in general).

Managing large volumes of data is already a mission critical topic in bioinformatics, where many core facilities are overworked. They do their best to keep up with the demand, but going forward there will be more data, more projects and more people to support. How will bioinformatics keep up? Download the full e-Book! »

VarSeq Reports Templates
Clinical Reports � New & Improved Templates!
by Hauwa Yusuf,
Field Application Scientist

Clinical reports come in all shapes, sizes and flavors. With that in mind, our clinical reporting interface VSReports was built to be highly customizable and flexible. With a little Javascript and HTML know-how, your clinical reports can be customized to meet the needs and goals of your lab. With a little Javascript and HTML know how, you can customize yours as well!

Coming up in our next VarSeq release, we've updated our report templates to showcase some variability in look, feel and information presented.
Continue reading »

Alternate Allele Frequency and VCF file format
by Jami Bartole,
Field Application Scientist

VCF file format comes with a lot of interesting quality assurance and statistics fields that can be used for filtering in VarSeq. Open your files in a text editor to see all the fields that are available in your files, each field will have a header line with a description of its content. See the VCF Specifications to help with interpretation of the information.

One of the most used values for filtering variants in a somatic mutation workflow is the Alternate Allele Frequency for each sample.
Continue reading »

GBS Workflows
Genotyping by Sequencing (GBS) Workflows in SVS
by Greta Linse Peterson,
Director of Services

Did you know you can analyze your Genotyping by Sequencing (GBS) data in SVS? Well you can! You can combine tools for both GWAS quality control and analysis with tools for NGS data analysis to either identify SNPs in your dataset or to identify differences between populations or sub-species.

If your species has a reference sequence or even if you have a pseudo-map for your data, you can import it into our SNP & Variation Suite software and use the numerous tools available for quality control, association tests and visualization.
Continue reading »
   CEO Corner
Andreas Scherer
Earlier this month we were excited to see that Golden Helix was selected among the top 20 most promising biotech technology solution providers in 2016 by CIO Review. They are a reputable organization and this listing puts us in the same context as Illumina, DNA Nexus and Pacific BioMarker. We were very honored to be included. In fact, over the last 2 years we have had a rapid development of our full clinical stack which has culminated in the official release of VSWarehouse. This gives us a strong competitive advantage in the clinical marketplace and we are looking forward to seeing what the future holds.

   Latest Webcasts
Getting Started with VSWarehouse - The User Experience

As the number of samples and associated data volume in a testing lab increases, it becomes imperative for labs to leverage state of the art warehousing technology that not only organizes data, but also aides and enables researchers and clinicians to perform further analysis, and ongoing research. VSWarehouse offers a scalable, multi-project warehouse for NGS variant call sets, clinical reports, and a knowledge base of variant classifications. This webcast discusses 4 main topics regarding VSWarehouse and its capabilities.

Watch here!

Pharmacogenomic Prediction of Antracycline-induced Cardiotoxicity
The Canadian Pharmacogenomics Network for Drug Safety (CPNDS), recently discovered a novel gene (RARG) responsible for cardiomyopathy and congestive heart failure in cancer survivors and has developed clinical practice recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity in children after cancer treatment.Join us as Dr. Folefac Aminkeng, presents the CPNDS' important research efforts focused on understanding the role of genes in ADRs and developing drug safety solutions for cancer patients, initiatives which are critical to improving long-term survival outcomes.

Watch here!

   Customer Success
As we mentioned last month, Golden Helix reached 1,000 citations of our software! We have had several more publications throughout April, and we wanted to share the highlights:

Facebook     Twitter     Linked In     Blog   YouTube

About Golden Helix
Golden Helix has been delivering industry leading bioinformatics solutions for the advancement of life science research and clinical and translational medicine for over 16 years. Our innovative technologies and analytic services empower scientists and healthcare professionals at all levels to derive meaning from the rapidly increasing volumes of genomic data produced from microarrays and next-generation sequencing. With our solutions, hundreds of the world's top pharmaceutical, clinical laboratories, biotech, and academic research organizations are able to harness the full potential of genomics to identify the cause of disease, improve the efficacy and safety of drugs, develop genomic diagnostics, and advance the quest for precision medicine. Golden Helix products and services have been cited in over 1,000 peer-reviewed publications.